Argued. For petitioners: Jeffrey A. Lamken, Washington, D. C. For respondents: Paul D. Clement, Alexandria, Va.; and Colleen R. Sinzdak, Assistant to the Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.)

Two copies of model exhibits from the record on appeal received from counsel for petitioners.

Record requested from the U.S.C.A. for the Federal Circuit.

SET FOR ARGUMENT on Monday, March 27, 2023.

Motion to dispense with printing the joint appendix filed by petitioner GRANTED.

Response to motion from petitioners Amgen Inc., et al. filed.

Brief amicus curiae of Instil Bio, Inc. filed.

Brief amicus curiae of The Fynder Group, Inc. d/b/a Nature’s Fynd filed.

Brief amicus curiae of Intellectual Property Law Association of Chicago in support of neither party filed.

Brief amicus curiae of New York Intellectual Property Law Association in support of neither party filed.

Brief amici curiae of Intellectual Property Professors filed.

Brief amicus curiae of National Association of Patent Practitioners, Inc. filed.

Brief amici curiae of Diversified Researchers and Innovators filed.

Brief amicus curiae of Chemistry and the Law Division of the American Chemical Society filed.

Brief amicus curiae of Intellectual Property Owners Association in support of neither party filed.

Brief amici curiae of REGENXBIO Inc., et al. in support of neither party filed.

Brief amici curiae of Alliance of U.S. Startups and Inventors for Jobs (USIJ), et al. (1/5/2023) filed.

Brief amici curiae of High Tech Inventors Alliance, et al. in support of neither party filed.

Brief amicus curiae of AbbVie Inc. filed.

Brief amicus curiae of GlaxoSmithKline plc filed.

Brief of petitioners Amgen Inc., et al. filed.

Motion to dispense with printing the joint appendix filed by petitioners Amgen Inc., et al.

Motion to extend the time to file the briefs on the merits granted. The time to file the joint appendix and petitioners' brief on the merits is extended to and including December 27, 2022. The time to file respondents' brief on the merits is extended to and including February 3, 2023.

Motion for an extension of time to file the briefs on the merits filed.

Blanket Consent filed by Petitioner, Amgen Inc., et al.

Blanket Consent filed by Respondent, Sanofi, et al.

Petition GRANTED limited to Question 2 presented by the petition.

DISTRIBUTED for Conference of 10/28/2022.

Supplemental brief of petitioners Amgen Inc., et al. filed. (Distributed)

Brief amicus curiae of United States filed.

The Solicitor General is invited to file a brief in this case expressing the views of the United States.

DISTRIBUTED for Conference of 4/14/2022.

Reply of petitioners Amgen Inc., et al. filed. (Distributed)

Brief of respondents Sanofi, et al. in opposition filed.

Motion to extend the time to file a response is granted and the time is extended to and including March 14, 2022.

Motion to extend the time to file a response from February 10, 2022 to March 14, 2022, submitted to The Clerk.

Response Requested. (Due February 10, 2022)

DISTRIBUTED for Conference of 1/21/2022.

Brief amicus curiae of GlaxoSmithKline plc filed.

Brief amici curiae of Intellectual Property Professors filed.

Brief amici curiae of Association of University Technology Managers, Inc., et al.

Petition for a writ of certiorari filed. (Response due December 22, 2021)

Amgen Inc., et al., Petitioner, represented by Jeffrey Alan Lamken

Sanofi, et al., Respondent, represented by Matthew McManus Wolf

Sanofi, et al., Respondent, represented by Daniel Louis Reisner

Sanofi, et al., Respondent, represented by Victoria Lynne Reines

Sanofi, et al., Respondent, represented by Paul D. Clement

Sanofi, et al., Respondent, represented by George William Hicks Jr.

AbbVie Inc., Amicus Curiae, represented by Jonathan S. Massey

Alliance of U.S. Startups and Inventors for Jobs and and Innovation Alliance, Amicus Curiae, represented by Robert P. Taylor

Chemistry and the Law Division of the American Chemical Society, Amicus Curiae, represented by Justin James Hasford

diversified researchers and innovators, Amicus Curiae, represented by Jeffrey P. Kushan

GSK PLC, Amicus Curiae, represented by John M. Desmarais

High Tech Inventors Alliance and The Computer & Communications Industry Association, Amicus Curiae, represented by John D. Vandenberg

Instil Bio, Inc., Amicus Curiae, represented by John Randolph Labbe

Intellectual Property Law Association of Chicago, Amicus Curiae, represented by Charles W. Shifley

Intellectual Property Owners Association, Amicus Curiae, represented by Vanessa Y. Yen

Intellectual Property Professors, Amicus Curiae, represented by Mark A. Lemley

National Association of Patent Practitioners, Inc., Amicus Curiae, represented by Louis James Hoffman

New York Intellectual Property Law Association, Amicus Curiae, represented by Melvin C. Garner

Public Interest Patent Law Institute, Amicus Curiae, represented by Nina Kosana Srejovic

Regenxbio Inc., IGM Biosciences, Inc., Adaptive Phage Therapeutics, Inc., Amicus Curiae, represented by William G. Jenks

The Fynder Group, Inc. d/b/a Nature’s Fynd, Amicus Curiae, represented by Matthew James Dowd

United States, Amicus Curiae, represented by Elizabeth B. Prelogar